Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report
/in Dendritic Cells, International Publications, NSCLC /von 2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-77Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-64Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-502Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
/in International Publications, NSCLC /von 2011-01-01 / Therapy 2011 Jan;8(1):43-54Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2010-03-12 / Lung Cancer 2010 Nov;70(2):188-94Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
/in International Publications, NSCLC /von 2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57Mechanisms of murine dendritic cell antitumor dysfunction in aging
/in International Publications, Malignant Melanoma, NSCLC /von 2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de